<< First  < Prev   1   2   Next >  Last >> 
  • 19 Feb 2019 4:28 PM | Marion (Administrator)


    Ann Brum
    Joint Venture & Co
    T: 781-797-0144


    February 15, 2019 – Worcester, MA – Today, Cannabis Community Care and Research Network (C3RN), Veterans Alternative Healing (VAH), and Joint Venture & Co (JVCo) announced the launch of the 2019 Cannabis Advancement Series, a series of six cannabis science and community events held around Massachusetts designed to continue breaking the stigma around cannabis. The 2019 Cannabis Advancement Series will begin March 3 at District Hall, Boston, followed by Holyoke in April 18, Worcester in June 20, North Shore in August 22, Fall River in October 24, with the culminating event in Boston December 5. 

    The six events held around the state will host high-level speakers and educational content surrounding topics including: medical and adult-use cannabis, Veteran’s and their family members focused care, equity and diversity in the cannabis industry, research, cultivation, extraction, industry best practices, business and entrepreneur, and general health and wellness.

    At the launch event on March 3 from 11 to 4 PM at District Hall in Boston, speakers will include Dr. Lester Grinspoon, retiree from Harvard medical School, Dr. Peter Grinspoon, MGH, Commissioner Shaleen Title, MA Cannabis Control Commission, among other esteemed speakers. The full agenda can be found at

    Cannabis industry and healthcare vendors will have booths with built-in networking time for business to business and patient/consumer interactions. The event will be free and open to the general public.  For booth or sponsorship opportunities, please visit: or visit   

    Register to attend the FREE March 3 launch event: 195018

    About Cannabis Community Care and Research Network (C3RN)

    Cannabis Community Care and Research Network (C3RN) is a public benefit corporation (B Corp) based out of Worcester, MA that specializes in providing high-quality research and analytic services related to the impacts of medical and adult-use recreational cannabis. As a social justice-oriented research and analytics company, C3RN specializes in designing, monitoring, and evaluating models of integrating adult-use and medical cannabis to positively impact social, clinical, and public health outcomes. C3RN provides cannabis and health research and data analytic services, and consulting around cultivation, extraction, life sciences, technology, and medical cannabis patient care. In 2018, C3RN hosted a monthly Cannabis Science, Education, and Networking series in Massachusetts to showcase the latest cannabis innovations, evidence, and best practices. Learn more at:

    About Veterans Alternative Healing (VAH)

    Veterans Alternative Healing provides education, services, support, advocacy and opportunities for and to veterans interested in utilizing alternative healing approaches and methodologies in treating ailments or conditions which affect them mentally, physically, emotionally, or psychologically thereby reducing the use of opiates and other pharmacological drugs used to suppress and temporarily manage pain, symptoms, and mental health concerns without stigma. Learn more at

    About Joint Venture & Co

    Joint Venture & Co is a Boston-based business development agency who has embarked on a very ambitious goal; to make any client; from a timid first-time cannabis user to a large dispensary to a healthcare organization, comfortable with both personal and business decisions in the cannabis and wellness arena. Learn more at

  • 4 Feb 2019 10:55 PM | Marion (Administrator)
    By: Dr. Marion McNabb, CEO C3RN
    Feb 4, 2019

    Worcester, MA

    GO PATS! What another great win for a great team, proud to live in Massachusetts!

    But we have more work to do to fight medical cannabis stigma...

    Despite another great Super Bowl win for the Patriots last night, it is a real shame that 100 million viewers lost out on seeing an ad rejected by CBS about medical cannabis and its impact on health outcomes, developed by Acreage Holdings.

    The 60-second ad (or intended public service announcement) highlights journeys of those suffering with seizures, opioid addiction, and Veterans, and then details how medical cannabis has positively benefited their lives. Check it out – it’s well worth the watch and share. VIEW HERE -->

    Despite the footage having factual backing and real world application, CBS' actions only limits evidence-based medical cannabis education for the general public. Despite these setbacks, the courageous and powerful message produced by Acreage has set many citizens and groups into gear sharing the content, writing blogs about its “prohibition”, and generating discussions around the ethics of allowing alcohol ads and not medical cannabis.

    Acreages' call to action for medical cannabis will, and is, going viral.

    On Super Bowl night, C3RN set out to really see exactly what CBS ended up choosing to show to 100 million Americans instead of the life saving benefits of medical cannabis. So, we sat down during the game, documented, and classified all commercials the team saw (minus one or two breaks when the internet went out).

    What were the results? Out of 123 ads from kick off to the finish line...who ended up winning the airtime? Apparently, CBS prefers that we continue to watch more TV, with an alcoholic spritzer or beer in our hand, grab some insurance or a new T-Mobile line, and then check out the new cars on the market.

    However, an informed understanding of how a legal medical cannabis plant positively impacts pediatric seizures, addiction/recovery, Veteran’s health, and many others who face qualifying conditions is...well...not ok. CBS, you missed the boat on this one, and it’s a real shame. Maybe your actions will a cause of Acreages' video going viral?

    Total 123 Ads, breakdown by type: 

    • 23% TV Shows
    • 11% Alcohol
    • 11% Services
    • 10% Cars
    • 9% Food
    • 8% Products
    • 7% Mobile Phones
    • 4% Fast Food
    • 4% Sodas
    • 4% Healthcare/Benefactor Ad
    • 3% Entertainment
    • 2% Marines
    • 2% Movies
    • 1% Online dating 

    Well, given that only 4% of the ads during the Super Bowl were not necessarily commercially driven, but rather promoted social causes -- we still have a long way to go. 

    Why C3RN believes the Acreage ad matters, and why it should have been aired specifically in Massachusetts:

    1) Veterans in MA are three times more likely to overdose from an opioid addiction. (MA DPH)

    2) MA has one of the worst opioid epidemics in the United States with 1 out of 5 people dying per day. (MA DPH)

    3) Medical cannabis is not a silver bullet but has been shown to be a promising harm reduction strategy for opiate addiction/recovery. (Lucas, 2018) 

    4) No one has ever clinically overdosed from cannabis (NSEM, 2017) 

    5) In our Massachusetts open cannabis consumer and patient survey, 63% of cannabis consumers and patients are using cannabis to reduce unwanted prescription medication intake. (C3RN, 2018) 

    Just like this Acreage ad implores, denying reality is unethical – and the time to act is NOW.

    We HAVE the tools we have in place NOW – we need leaders like Acreage to continue to break the stigma and increase access to medical cannabis.

  • 17 Jan 2019 2:01 PM | Marion (Administrator)


    HOUSTON, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Indoor Harvest Corp (OTCQB: INQD), is a precision agriculture technology company, focused on producing bio-pharma grade Cannabis for the wholesale and research Cannabis markets, as well as development of next generation personalized medicines. The Company is pleased to provide its shareholders guidance for 2019.

    Special Meeting of Shareholders

    The Company is hosting a virtual special meeting of shareholders on January 31, 2019 at 10:00 a.m. (Central Time). Common stockholders and Series A convertible preferred stockholders who were record holders on December 7, 2018 will be able to attend the special meeting, vote, and submit questions during the meeting via live webcast by visiting To enter the Special Meeting, you must have your 16-digit control number that was mailed to shareholders of record on December 21, 2018. If you were a shareholder of record on December 7, 2018 and have not received a proxy statement from the Company, please email 

    The purpose of the meeting is to amend and restate the Company’s certificate of formation in order to increase the amount of shares of capital stock authorized to be issued, to grant the Board of Directors (the “Board”) “blank check preferred stock” authority allowing the Board to fix the terms and issue new series of preferred stock without the approval of the holders of the Company’s common stock, to explicitly permit stockholders of different classes of the Company’s capital stock to vote as a single class with regard to changes to the certificate of formation, and to decrease the vote required for the approval of fundamental actions and fundamental business transactions.

    The Board believes it is in the best interests of our shareholders to increase the number of authorized shares of capital stock and to allow the Board to issue preferred stock and to fix its terms without further approval of the holders of Common Stock in order to give us greater flexibility in considering and planning for future potential strategic transactions, including mergers, acquisitions and business combinations, as well as other general corporate transactions, as further discussed below.

    “I want to take this opportunity to thank you for your continued support of Indoor Harvest and to express my appreciation for your commitment to the Company. The Cannabis industry experienced some significant events over the last 18 months and we believe that things are just getting started. I and the rest of the management team are working hard to position the Company for success as the industry develops, grows, and becomes more mainstream. It is an important proxy vote and we encourage you to support it by voting YES.

    Without the support of at least 2/3s of the shareholders, we will not be able to issue additional shares for the Company to raise vitally needed capital to continue operations and to move forward with management’s plans. It is important for you to vote YES.

    The proxy will allow the Company to increase our Authorized Shares of Common Stock from 50m to 200m which in turn will provide us with currency to complete strategic acquisitions and form strategic partnerships as well as raise additional capital”, stated Daniel Weadock, Chief Executive Officer of Indoor Harvest Corp.

    Moving Corporate Headquarters to Boston, Massachusetts

    Management is currently moving the base of operations and focus to the Boston area to take advantage of what it believes to be an attractive environment for Cannabis companies since Massachusetts has now legalized both medicinal and recreational Cannabis. The state is also offering a Cannabis research license, which provides a unique opportunity to do research & development on the medicinal side of the Cannabis industry.

    Management is working to deploy our integrated aeroponic technology platform, on our own and with partners in the Boston area, to demonstrate and showcase our belief in the technology’s ability to significantly reduce operating costs while increasing yield and quality. Deployment of our integrated aeroponic technology platform will also allow us to continue research and development of the technology with the goal of moving towards commercialization.

    We have been working the Boston market for the last year developing relationships on the ground with what we believe to be strategically aligned and vertically integrated potential partners. Two of these relationships include: Cannabis Community Care and Research Network (C3RN) who are working on the creation of a global virtual center of excellence for the Cannabis industry, and Integrated Genetics & Biopharma Research LLC, which is expected to provide boutique commercial grade genetics and tissue culture services to cultivators and researchers in Massachusetts.

    Joint Venture between Cannabis Community Care and Research Network (“C3RN”) and Integrated Genetics & BioPharma Research (“IGBR”)

    The Company has signed a Memorandum of Understanding (“MOU”) towards a proposed joint venture by and among C3RN and IGBR. Under the MOU, the Company will work with C3RN and IGBR to develop a business plan to acquire a license to conduct research on medical Cannabis. The joint venture group will conduct research on the use of Controlled Environment cultivation technology to influence how Cannabis plants express different chemical profiles to further development of next gen bio pharmaceutical grade products.

    C3RN runs a network of academics, Cannabis industry participants, healthcare providers, and other stakeholders interested in advancing collaborative and community-driven science approaches in Cannabis research in Massachusetts. C3RN also leads, in collaboration with UMass Dartmouth, a Cannabis consumer and patient citizen science research study, and partners with local Cannabis businesses to improve evidence-based patient care in Massachusetts. In October 2018, C3RN was selected as qualified training vendor for the Cannabis Control Commission’s (“CCC”) social equity program, pending further contract negotiations with the CCC. C3RN intends to leverage these strengths in this joint venture, with a focus on social equity and advancing rigorous Cannabis research.

    “It is very exciting for C3RN to start on the process of obtaining a research license to study Cannabis in Massachusetts as our company spent significant time advocating for the inclusion of research as an adult-use license category here in Massachusetts. Through this MOU with Indoor Harvest and IGBR, we are ready to take the next step towards licensure and to continue to generate scientific evidence and highlight best practices at the forefront of the industry,” said Dr. Marion McNabb, CEO of C3RN.

    IGBR is seeking dual licensure (Cultivation and Research) within Massachusetts under the recreational marijuana regulations 935 CMR 500.00. IGBR is an industry leader in intellectual property and best practices in propagation, cultivation, and Cannabis genetics. IGBR is also currently in possession of over 100 of the most desired strains and elite clone-only cuts on the recreational and medical Cannabis market. Mr. Dan Weadock, Indoor Harvest’s CEO, is also a co-founder of IGBR and acting as its CEO.

    “Our genetic research and development is based on both data and decades of Cannabis experience. We have established proprietary criteria and analytics in selecting cultivars that drive the market and provide cultivators with a distinct genetic advantage,” stated Douglas Klier, Founder and Chief Science Officer at IGBR.

    The proposed joint venture will work to identify and publish best practices for cultivation of Cannabis through rigorous research and development. Additionally, the joint venture group aims to provide data and develop partner-specific research studies and objectives with academic and other research institutions.

    “As part of the ongoing change management efforts and repositioning of Indoor Harvest, we have executed this MOU to help imagine a collaborative research and development effort between three strategically interrelated organizations. We believe this effort will provide the opportunity to create transformative intellectual property that can be leveraged for the collective gain of both the joint venture and its constituent entities”, stated Dan Weadock, CEO of Indoor Harvest and Co-Founder and CEO of IGBR.

    The Company intends to secure consensus among impacted stakeholders and work towards definitive agreements between the MOU parties and to secure funding during the second quarter of 2019, pending the approval of shareholders in passing the needed increase in the Company’s authorized capitalization at the special meeting.  

    Texas Compassionate Use Program Pending Applicant

    The Company’s wholly owned subsidiary, Alamo CBD, is currently a pending applicant to produce Cannabis in Texas under the Compassionate Use Program. As of December 17, 2018, only 576 patients were registered with the Compassionate Use Registry out of an estimated pool of 150,000 eligible patients.  The Company and many advocates believe the state’s approval of just three producers has led to low participation in the program.

    State Sen. José Menéndez, D-San Antonio, has filed a measure to expand the list of medical conditions that qualify for medical Cannabis under the Compassionate Use Act, to include illnesses such as Crohn’s disease, terminal cancer, autism, and PTSD. The measure would also remove the 0.5 percent cap on the amount of THC that medical Cannabis products sold under the Compassionate Use Act are legally allowed to contain.

    Connor Oakley, Executive Director of the Medical Cannabis Association of Texas (MCAT), believes that enough pro-medical Cannabis candidates won seats in the Texas Legislature to finally enact major medical Cannabis legislation. “We feel that we finally have the votes to get some of our bills passed,” Oakley said. “We have support from both sides of the aisle this time.”

    Currently there are a total of 13 Cannabis related bills being filed for the 2019 Texas legislative session. Additionally, the Texas Republican Party approved medical Cannabis and industrial hemp reforms in the summer of 2018. Due to the mounting support for Cannabis in the state, the Company believes the Compassionate Use Act will be expanded during the 2019 legislative session and that pending applicants such as Alamo CBD will be allowed to proceed forward. There is no guarantee of expansion, however, or that any of the filed measures will pass. 

    Summary Guidance for 2019

    Management believes that working with these organizations and others like them in Massachusetts positions us well to move our agenda forward and provides us with an opportunity to demonstrate our technology and how it can be used to significantly decrease operating costs while increasing yield, potency and quality.

    While pursuing strategic partnerships and building our demonstration showcase, management is also working to clean-up the Company’s balance sheet and to position us for a potential merger or strategic investment involving other vertically aligned Cannabis industry companies. Management is actively pursuing a number of these opportunities. The goal of this effort is to find a strategic partner that will bring revenue and cash flow to the Company as well as provide the opportunity to put our technology in the field.

    Management believes that its efforts in Massachusetts and further developing strategic partnerships will allow the Company to successfully continue operations and create real shareholder value. We encourage you to vote YES on the proxy and give management the tools it needs to grow and expand our business while enhancing shareholder value.

    About Indoor Harvest Corp

    Indoor Harvest Corp (OTCQB: INQD), is a precision agriculture technology company focused on delivering pharmaceutical grade Cannabis for researchers, and the development of next generation personalized medicines. The Company is a pending applicant to produce Cannabis under the Texas Compassionate Use Program and is seeking additional licenses in the State of Massachusetts.

    Forward-Looking Statements

    This release contains certain “forward-looking statements” relating to the business of Indoor Harvest and its subsidiary companies, which can be identified by the use of forward-looking terminology such as “estimates,” “believes,” “anticipates,” “intends,” expects” and similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our filings with the Securities and Exchange Commission. These forward-looking statements are based on Indoor Harvest’s current expectations and beliefs concerning future developments and their potential effects on Indoor Harvest. There can be no assurance that future developments affecting Indoor Harvest will be those anticipated by Indoor Harvest. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the Company) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by such forward-looking statements. Indoor Harvest undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

    Contact Information

    Indoor Harvest Corp
    Dan Weadock, Chief Executive Officer

  • 14 Dec 2018 12:21 PM | Marion (Administrator)

    Original Article:

    Cannabis Researcher Moves to Worcester

    Worcester Business Journal, by Zachary Comeau

    Cannabis Community Care and Research Network, a state public benefit corporation in the cannabis industry, is moving to Worcester.

    The organization said Friday it's moving to the city to better serve the industry, healthcare providers, patients and recreational customers.

    "C3RN is excited to move our headquarters to Worcester," said Marion McNabb, CEO of C3RN. "This strategic move will allow C3RN to work more closely with our partners in Central and Western Massachusetts to expand our cannabis research, community health, and education services within the industry."

    The organization did not say when it would be moving or where its headquarters would be.

    The move follows suit with the Cannabis Control Commission, the state's cannabis industry regulatory body, which is planning to move into Union Station.

    Simultaneous to the Worcester announcement, C3RN announced the preliminary results from an ongoing cannabis science study. Among 1,325 Massachusetts respondents, 33 percent said they used cannabis most commonly for pain, followed by 26 percent for anxiety and 14 percent for depression.

    Sixty-three percent of survey respondents said cannabis products helped to reduce their intake of prescription medicine. The most common type of medications included antidepressants (24 percent), narcotics or opioids (15 percent), muscle relaxers (14 percent) and non-opioid analgesics (16 percent).

    When asked if cannabis helped deal with physical symptoms, 65 percent said it did. Another 71 percent said it helped with psychological problems and 75 percent said it just helped with their overall quality of life.

    A peer-reviewed manuscript with more data is being developed by C3RN and UMass Dartmouth for submission to a scientific journal. C3RN will present this data and host workshops at the Harvest Cup at the DCU Center on Sunday.

  • 23 Nov 2018 11:25 AM | Anonymous member

    If you’re growing indoors, you have height restrictions that not only effect the way you grow, but effect your actual harvest quality and yield. And regardless of which lights you use, a traditional overhead grow light cannot penetrate lower branches, which can substantially limit yield.

    But with Trella’s automated plant training system, lack of height is no longer limiting growth potential. As we continue refining our next design and making the system ready for home and commercial cultivators, check out the various ways you can train your plants to optimize plant growth and increase yield by 25%-40%.

    Topping, Supercropping and Scrogging

    These techniques all require pruning of branches at the lower part of the plants. Removing these branches prevents waste of water and nutrients, but also reduces the number and size of colas a plant will produce. Learn more about these methods here.

    Low-Stress Training

    Low-Stress Training is a method near and dear to Trella because our system combines the benefits of low-stress training with automation. Also, low-stress training doesn’t require any actual cuts, which can damage plants and slow down or inhibit growth.

    With gentle bending of branches, low-stress training allows the plant to grow in a sideways direction, letting all side branches receive more optimal light and grow into their own cola. Unlike with the training methods mentioned above, where branches are trimmed, horizontal growing through low-stress training allows growers to keep all branches intact and therefore maximize yields.

    Increase Yield.png

    Click here to learn more about Trella’s patent-pending design.

  • 1 Nov 2018 11:34 AM | Marion (Administrator)

    Original Article Found Here:

    Cannabis Center of Excellence' to launch online hub of research, analysis, event, product details

    Updated Nov 1, 6:18 AM; Posted Nov 1, 6:18 AM


    Gallery: 'Cannabis slowly but surely playing role' in pain treatment, says panelist in Holyoke forum

    By Mike Plaisance

    SPRINGFIELD -- An online headquarters of marijuana insights, discussions and research is scheduled to launch today by a Somerville industry advocate and consultant.

    "The Cannabis Center of Excellence provides an online platform to connect our community of academics, cannabis industry, healthcare professionals, consumers and patients aiming to advance cannabis research and science," according to

    The website was spearheaded by the Cannabis Community Care and Research Network (C3RN).

    The site will provide information about research, analysis, consulting, marketing, products and events, the website said.

    Membership tiers are platinum, $500 a month, gold, $250 a month, silver, $75 a month, community advocate, $5 a month, and community partner for free, the website said.

  • 19 Oct 2018 11:20 AM | Anonymous

    Holyoke, MA – October 19, 2018 - Cannabis Community Care and Research Network (C3RN) is pleased to announce on October 18th that the team was selected as a qualified vendor for the first state-wide social equity program. C3RN wrote a proposal to work Holyoke Community College (HCC) and the City of Holyoke to develop cannabis workforce training programs for Holyoke and the surrounding regions, funded by the Massachusetts Cannabis Control Commission. The project scope, collaborative partnerships, timelines, and next steps are subject to further negotiations with the Cannabis Control Commission.

    C3RN, HCC, and the City of Holyoke proposed to design a pilot model workforce training and competency-based internship/apprenticeship program for four entry-to mid-level occupations to meet the growing cannabis workforce needs in Holyoke and the Region.

    This model cannabis education-to-employment program will build on HCC and the City of Holyoke’s efforts to revitalize the city and surrounding areas and will bring the highest-level of evidence-based education to the workforce.

    “Today’s decision by the Cannabis Control Commission for the C3RN selected as qualified vendor and C3RNs partnership to have Holyoke be a site for Social Equity Training will bring lasting economic impact in our City” said Mayor Alex Morse. “We already offer the best cost profile and platform for cannabis growing in the state, adding to that the workforce development component will only strengthen the industry’s success here further, as well as its positive impact for our residents.”

    Holyoke is one of the first industrially planned Cities in the country, boasting a municipally-owned Gas & Electric Company that provides some of the cheapest electric rates in Massachusetts and New England, primarily from its hydroelectric resources. Affordable and plentiful water and mill real estate complement the City's attractive profile for this activity. City residents and municipal government have enthusiastically embraced the cannabis industry as an economic cluster and have seen early success by attracting and permitting companies that will grow, process and sell cannabis products.

    An integral part of ensuring the success of these companies and growth of the Holyoke and surrounding economies, the team proposed to develop four comprehensive training, internship, and apprenticeship programs for emerging cannabis occupations.

    After students receive core competency training, they will be paired with one of over 51 cannabis companies, academics, ancillary businesses, consultants, experts, and other stakeholders who have signed on to be a member of the C3RN/HCC training, internship, and apprenticeship network. C3RN and HCC plan to train job seekers from Holyoke and surrounding areas for four new workforce occupations:

    • Cannabis Cultivation Assistant
    • Dispensary Patient Advocate/ “Bud Tender”
    • Extraction Technician Assistant
    • Cannabis Pantry Cook/Cannabis Culinary Assistant

    “This is an important step in establishing an educated, informed, and standardized workforce for the cannabis industry while providing a streamlined process for employment for social equity applicants,” said Dr. Miyabe Shields, PhD, director of Education for C3RN. “The cannabis industry is at a critical point of its development and we are thrilled to be able to assist the CCC in creating employment opportunities and raising the bar for cannabis education across the board.”

    The proposed C3RN/HCC training and internship/apprenticeship certificate program will be designed for cost-effective and sustainable scale to all of Massachusetts and other community colleges with a focus of highlighting inclusion for all, celebrating diversity, and promoting equity – including prioritizing the 29 cities of disproportionate impact as defined by the CCC. Massachusetts has also prioritized the 29 “Gateway Cities” – those with a need to revitalize industries.

    “We are hopeful the training models produced in this project will have wide, culturally relevant, lasting, and technically sound impacts on addressing stigma against cannabis use in Massachusetts, the U.S., and globally.” said Dr. Marion McNabb, DrPH, MPH, CEO of C3RN.

    This new-to-Massachusetts industry provides employment opportunities especially for those communities with high levels of poverty and unemployment. The team hopes to be the leaders in setting the standard for certificate training and innovative models of bringing those who have operated in the industry for decades into the new, legal and regulated market.

    “The goal of this one-year pilot program will be to train and link students to employment opportunities for those from Holyoke and greater Western Massachusetts,” said Jeff Hayden, Vice President of Business and Community Services at Holyoke Community College.

    “The purpose of this two-pronged training is to help individuals get placed in a job and to find long-term career pathways.” Hayden added that there will not be any cannabis or cannabis products on the HCC campus or on any of its off-campus sites where training may take place.

    “Further contract negotiations pending with the CCC, the proposal intends to train students in customer service, dosing, and extraction methods and techniques, but when it is time for students to work with actual product, that will take place offsite through our partner C3RN,” he said. “As the education partner, we want to ensure that local residents and students have access to opportunities – including those in emerging industries such as cannabis – that lead to jobs.”

    There is also a clear need for restorative justice in the emerging cannabis industry – ensuring those who have worked in this industry for decades have meaningful leadership and pathways for employment and entrepreneurship.

    “One of the most exciting parts of this collaboration is a “Cannabis Life Credit” program that prioritizes access and ‘transfer’ credits for individuals that have prior convictions, experience, or expertise in any aspect of the cannabis industry. We hope to fast track those operating in the unregulated market to the new legal, regulated industry with pride and respect for the deep expertise that lies there. It’s time for a new era of cannabis justice, and we are honored to play a role in making that happen.”, said Randal MacCaffrie, Co-founder of C3RN and Chief Vision Officer.

    Future plans for the project and collaboration with other social equity training vendors selected will be dependent on next steps identified by the Cannabis Control Commission.

    Do you want to continue to stay updated and support cannabis research, science, evidence-based, and collaborative education?

    Join our Massachusetts State-approved group of like-minded businesses, academics, healthcare providers, consumers, and patients all committed to open change through education! Here are some ways to take action and join!

    A few options for participating in this new academic and internship network include:

    • ·       Be a subject matter expert, internship, or job site with C3RN and HCC
    • ·       Support equity-focused initiatives and groups in the 29 cities identified as disproportionately impacted by the drug war in Massachusetts
    • ·       Contribute your ideas, science, or data to drive social change and incite scientific discovery in cannabis


    Anyone interested in joining the program or in advancing evidence-based cannabis education to develop a strong, safe, and regulated cannabis industry visit to become a C3RN/HCC partner. Full services will launch on November 1, 2018.

    About C3RN

    Cannabis Community Care and Research Network (C3RN) is a woman-owned public benefit corporation based out of Somerville, MA formed in January 2017 with the goal of advancing the science, education, and research around adult-use and medical cannabis in the Commonwealth of Massachusetts. The overall goal of C3RN's work is to break down silos and advance the evidence-base by connecting stakeholders to educate, share best practices, change healthcare and research paradigms, and promote restorative justice for those who have disproportionately affected by the drug war in Massachusetts and beyond. C3RN specializes in designing, monitoring, and evaluating models of medicinal and adult-use cannabis to break stigma, positively impact social, clinical, and public health outcomes. At present C3RN is operating an innovative open-data community-driven research study and orchestrating further research and related projects in the cannabis space. The company, with input from clinical research partners, designed The Anonymous Open Cannabis Consumer and Patient Survey which has been put out nationwide in partnership with the University of Massachusetts Dartmouth.

    On November 1, 2018 C3RN will formally launch a virtual cannabis center of excellence – an online platform for connecting with cannabis and healthcare experts, companies, academics, consumers, and patients interested in advancing cannabis science and research.

    Join to be a leader in developing how research, science, and community will drive the cannabis industry -

    About HCC

    Holyoke Community College is the Commonwealth’s oldest community college, serving more than 11,500 students annually in credit and noncredit programs and courses. The college holds transfer agreements with more than two dozen colleges and universities. Recognized for its Honors Program, online learning curriculum, learning communities, and service to students, HCC also offers business development opportunities through the Kittredge Center for Business and Workforce Development. In September 2016, HCC became a federally recognized Hispanic Serving Institution. Please visit us on the web at


    Cannabis Community Care and Research Network (C3RN)

    Dr. Marion McNabb, DrPH, MPH
    CEO and Co-Founder
    (404) 985 – 8149

    Holyoke Community College

    Chris Yurko
    Media Relations Manager
    (413) 552-2259 (office)
    (413) 977-1255 (cell)

    City of Holyoke

    Marcos A. Marrero
    Director. Planning and Economic Development
    City of Holyoke
    (413) 322-5575
    (413) 322-5576

  • 4 Oct 2018 8:15 PM | Randal (Administrator)

    By the end of this year the Cannabis Control Commission will be taking over the task of overseeing the medical marijuana program from the states Department of Public Health. Before this happens though the state has opened a public comment period to gather feedback on the design of the regulations surrounding the program. This is a very important time as this is a chance to correct some of the legislation that has hindered the program up until now. That being said, what are some suggestions for public comment you might ask?

    First off the biggest barrier to entry for most patients is money. Now that the CCC will be in control of the program they should theoretically be bolstered with tax money to run the program. Currently there is a 50 dollar fee to the Department of Public Health. This fee should be removed from the legislation in order to drive the cost of becoming a patient down.

    Another problem with the program is the difficulty of registering and navigating the website in order to receive confirmation of participation in the program. It can be a daunting task for someone who is not computer savvy. Streamlining this process by having an instant signup at the doctor's office will significantly ease the burden that current medical patients face.

    The Commonwealth of Massachusetts is home to a huge influx of medical tourism, meaning people from all over the world come to the state to have procedures done at the many amazing medical facilities the state. I would propose that doctors be allowed to certify patients for 1,2, or 3 month temporary certifications to people from out of state. I believe this may allow doctors to feel more secure about suggesting cannabis as an alternative therapy to medications such as opiates.

    Of major concern is the current regulations for pediatric care. Currently under the DPH guidelines it takes two pediatric physicians to certify a patient, Because there are so few doctors that do certify in the commonwealth this has caused and continues to cause barriers for patients that are out of time. that being said if a family is considering cannabis to treat their sick child I can assure you it is probably a life or death situation or a major health and quality of life decision.

    The open public comment period runs until October 29th. Electronic comment can be sent to, so get those comments in and be the change you wish to see.

  • 1 Sep 2018 12:50 PM | Marion (Administrator)

    Why cannabis works for me: Groundbreaking survey sets out to discover how and why people use medical marijuana across America

    Why cannabis works for me: Groundbreaking survey sets out to discover how and why people use medical marijuana across America

    • Cannabis Community Care and Research Network launched study to build up picture of use in real-time
    • Aims to reduce stigma around medicinal prescriptions and help build picture of wider use
    • Researchers believe the cannabis industry will outgrow cable TV to become a $40bn-a-year industry within a decade 
    • INSA CEO Mark Zatyrka said: 'The scientific data also helps to discredit the stigma that still surrounds cannabis


    PUBLISHED: 13:48 EDT, 1 September 2018 | UPDATED: 16:43 EDT, 1 September 2018



    View comments

    groundbreaking new study is underway to better understand why and how patients across America use medical marijuana. 

    The anonymous survey is a first and aims to help standardize health and safety for cannabis users and improve the health of medicinal, and recreational users. 

    Dr Marion McNabb, Public Health Doctor, CEO, and co-founder of C3RN, said: ''We're focusing on designing innovative research and education models that embrace community-level engagement and empowerment to collectively drive change. 


    I am a 36 year old female INSA patient with multiple health issues. I get severe migraines. I was diagnosed with bipolar disorder, generalized anxiety disorder, and ptsd during my teenage years. In my twenties I was diagnosed with fibromyalgia and interstitial cystitis. After years of medicating and seeing little results I was willing to try anything new. I received my mmj license hoping it would help with panic attacks I was having on a daily basis and severe pain from fibromyalgia. The first thing I noticed was it helped my depression and I was so much happier. My panic attacks had almost disappeared. My pain had lessened to the point where I have almost completely cut out all pain medication. My migraines are controlled if I medicate at the onset. The biggest surprise I had was with the interstitial cystitis also known as painful bladder disease. It affected every aspect of my life from waking up six times a night to use the bathroom to not going anywhere during the day because I had to use the restroom constantly. I can now sleep almost completely through the night usually only getting up once. I have experimented with different forms of mmj to find out what works best for me. It was trial and error. I find that I do not like to smoke which I thought everyone else did. What works best for me are the 1:1 cbd thc options. Insas 1:1 ginger tea hard candy and fruit chews are the best. I also like the cbd and thc patches for pain which last 12 hours. INSA is the only dispensary I know that sells ground flower at such a low price. I buy the ground flower and make my own vaginal suppositories for my bladder issues. I use the vape at the onset of my migraine and that usually stops it. They have so many options it's impossible to not find something that works for you. Medical marijuana has improved the quality of my life 100%. I am happier than I have ever been and I challenge anyone who has a debilitating health issue to give it a try because it could change your life. Thank you for reading my story.

    'This longitudinal anonymous survey is meant to give everyone a voice and an opportunity to be part of this movement.'

    'The baseline information established here will be used to develop accessible, innovative, and evidence-based community education resources. 

    'We intend to highlight collective best practices that promote multi-sectoral collaboration between the cannabis industry, healthcare, academic, consumers and patient populations.'   

    Three centers in Massachusetts have chosen to prioritize research and evidence-based education during this pilot in order to provide the highest quality of care to their patients: INSA in Springfield and Easthampton, MA; BASK in Fairhaven, MA; and Revolutionary Clinics in Somerville and Cambridge, MA. 

    INSA CEO Mark Zatyrka said: 'The data that C3RN presented tonight is so valuable because it immediately adds legitimacy and credibility to the fact that this plant is not only helping people but improving their quality of life in a major way. 

    'The scientific data also helps to discredit the stigma that still surrounds cannabis. Medical cannabis affects our communities in a major way. And I mean in a positive way. 

    'We hear the stories of our patients. These are real people dealing with really tough ailments in difficult situations. Data is made up of numbers, but those numbers are made up of real people. Those patients who benefit from this plant, their lives are changed forever'.

    Those that take the survey will immediately see their results compared to Massachusetts and national findings, receive dispensary discounts. 

    'It's great to see Massachusetts medical dispensaries taking such a strong pro-research stance,' says Dr. Christina Miyabe Shields, director of education for C3RN. 'They are really tackling the problem of stigma head-on.'

    'Before I studied the endocannabinoid system, I was so traumatized by the stigma - I felt ashamed, even when I knew Cannabis was the safest, most therapeutically potent drug for me,' she says. 'But after completing my PhD in pharmaceutical sciences, I now understand the role that propaganda and other political fear-mongering techniques have played in creating this stigma in Western medicine.' 

    'Participating in our survey is the first step that anybody can take in changing the stigma of Cannabis use,' Dr Shields states. 

    'Ultimately, the data produced will help provide specialized care for the entire community of patients. This in turn should empower the cannabis industry to reach towards a higher level of education and implementation of best practices. 

    The results of the survey will be presented on September 23, 2018 at the final event of the 2018 C3RN Cannabis Science, Education, and Networking Series, which will be held in Boston.  

    To take part in the study visit, click here   

    C3RN claims the cannabis industry will be worth $40 billion a year within a decade

    C3RN claims the cannabis industry will be worth $40 billion a year within a decade

  • 29 Aug 2018 10:02 AM | C.

    In a recent release, Dr. Matthew Roman documents his method for treating autism-related self-injury with medical marijuana. He recommends inhaling 2-4 breaths every 1-2 hours with a vape pen. Orally inhaling marijuana has many advantages for this specific therapeutic use. Not only does it have a quick onset time (about 10 minutes) and allow you to slowly increase the dose (wait 10 minutes between breaths and take more as necessary), but it also has a relatively short duration of action (1-3 hours) before it fades away. The method of drug delivery is very similar to an inhaler for asthma.

    I have only recently begun my public journey into Cannabis advocacy. I had been so consumed with obtaining the right education in cannabinoid pharmacology that I totally overlooked how difficult it would be to then use that knowledge to help educate the public. I've been made more and more aware of what it means to speak out for Cannabis use as a medicine and stand up to what I believe is its best therapeutic use: as a mental health pharmaceutical. I was just starting to feel the fear creep in, "Oh no, maybe I shouldn't be blogging about marijuana and my mental health. People already think such horrible things about me being queer and having tattoos!" But then I read the end of Dr. Roman's post summarized above:</span>

    "While my experience is only one anecdotal data point, it is one of few out there and thus it can be used comparatively. There is nothing out there related to medical marijuana as an abortive therapy for self-injury in patients of any age with ASD."

    Whether you agree or disagree with the politics and stigmatization behind marijuana, what you cannot change is the fact that this is an option, right now, to try to stop someone's uncontrollable pain - not ten years from now, not twenty, today. As someone who has used self-harm extensively as a coping mechanism, I know that when you no longer need to, you feel an immediate surge in confidence and an increased trust in your own ability to become happy.

    When inhaling marijuana, the chemicals in the smoke are absorbed through the lungs into the bloodstream and then travel to your brain where they turn on the CB1 and CB2 receptors. These receptors, generally speaking, are in the business of identifying and stopping overstimulated brain cells. So if there's a brain cell that is firing too rapidly, the CB1 receptor is activated and sends a signal to the cell to stop firing as much. Though the exact molecular pathway cannot be traced yet, it's clear to me that it is through this effect, called "long-term depression" (don't be scared, "long-term" for cells is on the scale of milliseconds and seconds), that medical marijuana can have a beneficial abortive effect for self-harm. Overstimulation is an exponential experience. It ramps up and up and up and then once it passes an individual's threshold, every single additional sensory input is jarringly painful. Stopping this overstimulation by relaxing the brain cells parallels what I've experience.

    There have been many other stories of friends and families across the world who are using medical marijuana to help treat ASD, and the scientific literature is slow to keep up. One reason for this is the lack of background literature documenting the endocannabinoid system and ASD; the endocannabinoid system is more recently discovered than the other "significant" neurotransmitter systems in the brain like opioids, serotonin, and dopamine. And you need background literature to get grant funding. And you need grant funding to do anything.

    Until it catches up, we must continue moving forwards for now in the only way we can: anecdotally.

    Self-harm is an incredibly powerful coping mechanism to eliminate, because it works so well for its intended purpose. Pain is a very basic sensation that all brains prioritize over other activity so self-inflicting pain is a conscious and controlled focussing of the brain when it feels chaotic and out of control, which is also why it can be used for so many different purposes. The problem is that it causes damage, and we should strive to find coping mechanisms that don't cause us or others harm. I believe that marijuana can be very helpful for this purpose, because it can decrease the extra activity in the brain that leads to chaos that can snowball into self-harm as a coping mechanism.

    I didn't fully understand that I was using marijuana for this purpose when I was first exposed to it, but I did notice that I was able to completely stop some of my most harmful behaviors. As a recreational user, I was only aware that it was helping me. But now looking back, my introduction to Cannabis almost completely eliminated my most physically self-harmful behaviors. My baseline level of anxiety was vastly decreased which prevented me from reaching the critical threshold that led to self-injury.

    This is huge as it allows you to navigate the world with confidence and stability. When it comes to reducing self-harmful behaviors, preventative and relatively non-invasive therapeutic techniques such as music, physical activity, or Cannabis can make all the difference in someone's overall lifestyle.

<< First  < Prev   1   2   Next >  Last >> 


Powered by Wild Apricot Membership Software